Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
16.38 USD | +2.18% | +1.55% | +5.75% |
05/04 | North American Morning Briefing : Investors on -2- | DJ |
15/03 | UBS Adjusts Cryoport Price Target to $17 From $14.50, Maintains Neutral Rating | MT |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
- From a short-term investment perspective, the company presents a deteriorated fundamental situation
Weaknesses
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- Low profitability weakens the company.
- The company is in debt and has limited leeway for investment
- The company's enterprise value to sales, at 3.62 times its current sales, is high.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
- Over the past twelve months, analysts' opinions have been revised negatively.
- Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Air Freight & Logistics
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+5.75% | 805M | C | ||
-11.96% | 6.63B | - | ||
+30.45% | 5.41B | - | ||
+15.65% | 4.04B | D | ||
+12.25% | 2.26B | B- | ||
+5.06% | 995M | - | - | |
+93.91% | 931M | B | ||
-18.56% | 555M | - | - | |
+1.93% | 504M | - | - | |
-30.92% | 496M | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- CYRX Stock
- Ratings Cryoport, Inc.